.jpg)
Mathangi Gopalakrishnan received $200,000 and $75,000 contracts from Rubicon Research
Mathangi Gopalakrishnan, PhD, associate professor of practice, sciences, and health outcomes research and director of the MS in Pharmacometrics program, has received a 22-month $200,000 contract for “Proposal for RaldesyTM (trazodone hydrochloride) Oral Solution for Insomnia in Pediatric Patients with Autism Spectrum Disorder,” and a 22-month $75,000 contract for “Clinical Justification - RaldesyTM (trazodone hydrochloride) Oral Solution for Insomnia in Pediatric Patients with Autism Spectrum Disorder,” both from Rubicon Research.